Proliferative lupical glomerulonephritis/focal and membrane sclerosant – Lupical nephritis: case report
DOI:
https://doi.org/10.51723/hrj.v3i15.268Keywords:
Systemic Lupus Erythematosus. Proliferative Lupus Glomerunephritis. Treatment.Abstract
Introduction: Systemic Lupus Erythematosus (SLE) is a disease of autoimmune origin, causing chronic and multisystemic inflammation. Of unknown etiology, the onset of the disease can occur due to genetic and/or environmental factors. Glomerulonephritis (GN) is usually the main cause of the use of large doses of corticosteroids (CE) and immunosuppressants, which is the condition that most requires hospitalization and the main factor related to increased mortality. Case Description: Patient with morphological findings compatible with Lupus Proliferative Glomerulonephritis/Focal & Membranous Sclerosing – Classes III (A/C) + V, with “Full House” aspect, pattern in which IgG, IgA, IgM deposits are simultaneously detected C1q, C3. Conclusion: Systemic Lupus Erythematosus (SLE) is a multisystemic autoimmune disorder with a wide spectrum of clinical presentations. Lupus glomerulonephritis has developmental classes, divided from I to V, that follow the appearance of the kidney injury. Treatment includes corticosteroid therapy and immunosuppression.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Celina Riva Rodrigues, Renato de Carvalho Barros, João Pedro Ribeiro Alves, Luiz Eduardo Rangel de Araújo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Esta licença permite que outros distribuam, remixem, adaptem e desenvolvam seu trabalho, mesmo comercialmente, desde que atribuam crédito à revista pela criação original.